Skip links

Diversity is getting a dinner invitation. Inclusion is making sure everyone enjoys the meal

Jump To Section

If there is ever a contest for “two words that are lumped together most often”, “diversity and inclusion” would probably walk away with the prize.

Decoding Diversity vs. Inclusion

If there is ever a contest for “two words that are lumped together most often”, “diversity and inclusion in the workplace” would probably walk away with the prize.
And this lumping together has only worked negatively for “inclusion” for it has come to mean that diversity implies inclusion or worse, diversity means inclusion.

When you make a cake, you bring together a wide array of ingredients, but the ingredients on their own are separate. It’s what you do with those ingredients that matter.
Diversity on its own is just ingredients, but putting them all together into something wonderful and delicious is inclusion.

Even with all the talk on the matter, the number of organizations that truly perceive the nuances between diversity and inclusion is far too less.
As a result, they add a few women to a board or executive team and feel they’ve achieved D&I and can return to business as usual. Such a focus on diversity while largely ignoring inclusion amounts to nothing besides a checked box on a legal requirement or a certification survey.

The American analytics and advisory company Gallup’s research indicates that recognizing the distinction between diversity and inclusion is the first step in the journey towards creating a uniquely diverse and inclusive workplace culture.

Diversity is about the what – it focuses on the makeup of your workforce. Organizations are diverse when they have representation from individuals across the whole spectrum of race, gender, ethnicity, etc.
Inclusion, on the other hand, is about the how – it focuses on whether the said individuals feel welcome and valued for their contributions; if everyone is able to thrive and achieve their full potential.

While adding women to the board or promoting more people from marginalized communities might enhance diversity, it doesn’t necessarily change the culture of the organization or ensure that these underrepresented groups will feel fully accepted and included.

Diversity and Inclusion

In its 2018 report, The Diversity and Inclusion Revolution, Deloitte found that organizations with inclusive cultures were, among other things, six times more likely to be innovative and agile.

Here are a few simple, actionable ways in which a workplace can be made more inclusive:
1. Model inclusive language in all forms of communication
2. Provide trusted feedback systems for employees to escalate reports of discrimination
3. Create events and initiatives focused on celebrating diversity
4. Emphasize the business case for diversity and inclusion. Change the narrative from “diversity as a recommendation” to “diversity as an asset”
5. Provide sponsorship programs that aim to hire underrepresented brackets of the society – like women trying to return to work after a maternity break.

Empowering Diversity: Altimetrik’s WINGS

In Altimetrik, initiatives like WINGS intend to increase the representation of women in the company through programs like REBOUND (which strives to bring back women from a career break) and address women-centric issues and provide a safe space for women to collaborate and grow.

We live in a world that is only getting more and more diverse. Workplaces need to be a reflection of the society that their employees live in. Ensuring diversity and inclusion at places of work is no longer a perk but is a necessity – one we must all seek to achieve for the holistic success of an organization and the people who encompass it.

Aparna Prabhu

Aparna Prabhu

Latest Reads


Suggested Reading

Ready to Unlock Yours Enterprise's Full Potential?

Adaptive Clinical Trial Designs: Modify trials based on interim results for faster identification of effective drugs.Identify effective drugs faster with data analytics and machine learning algorithms to analyze interim trial results and modify.
Real-World Evidence (RWE) Integration: Supplement trial data with real-world insights for drug effectiveness and safety.Supplement trial data with real-world insights for drug effectiveness and safety.
Biomarker Identification and Validation: Validate biomarkers predicting treatment response for targeted therapies.Utilize bioinformatics and computational biology to validate biomarkers predicting treatment response for targeted therapies.
Collaborative Clinical Research Networks: Establish networks for better patient recruitment and data sharing.Leverage cloud-based platforms and collaborative software to establish networks for better patient recruitment and data sharing.
Master Protocols and Basket Trials: Evaluate multiple drugs in one trial for efficient drug development.Implement electronic data capture systems and digital platforms to efficiently manage and evaluate multiple drugs or drug combinations within a single trial, enabling more streamlined drug development
Remote and Decentralized Trials: Embrace virtual trials for broader patient participation.Embrace telemedicine, virtual monitoring, and digital health tools to conduct remote and decentralized trials, allowing patients to participate from home and reducing the need for frequent in-person visits
Patient-Centric Trials: Design trials with patient needs in mind for better recruitment and retention.Develop patient-centric mobile apps and web portals that provide trial information, virtual support groups, and patient-reported outcome tracking to enhance patient engagement, recruitment, and retention
Regulatory Engagement and Expedited Review Pathways: Engage regulators early for faster approvals.Utilize digital communication tools to engage regulatory agencies early in the drug development process, enabling faster feedback and exploration of expedited review pathways for accelerated approvals
Companion Diagnostics Development: Develop diagnostics for targeted recruitment and personalized treatment.Implement bioinformatics and genomics technologies to develop companion diagnostics that can identify patient subpopulations likely to benefit from the drug, aiding in targeted recruitment and personalized treatment
Data Standardization and Interoperability: Ensure seamless data exchange among research sites.Utilize interoperable electronic health record systems and health data standards to ensure seamless data exchange among different research sites, promoting efficient data aggregation and analysis
Use of AI and Predictive Analytics: Apply AI for drug candidate identification and data analysis.Leverage AI algorithms and predictive analytics to analyze large datasets, identify potential drug candidates, optimize trial designs, and predict treatment outcomes, accelerating the drug development process
R&D Investments: Improve the drug or expand indicationsUtilize computational modelling and simulation techniques to accelerate drug discovery and optimize drug development processes